4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001797826-26-000006
Director sold 11,439 shares at an average $22.90 ($261,929)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Thornberry Nancy · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-02 | Sale : show line 1 in the form 10b5-1 | −10,824 | $22.85 | $247,328 | 20,301 | D |
| 2026-09-02 | Sale : show line 2 in the form 10b5-1 | −615 | $23.74 | $14,600 | 19,686 | D |
| Open-market sales · 11,439 sh · avg $22.90 · $261,929 | ||||||
Loading xslF345X06/wk-form4_1788555742.xml…